Dr. Parveen Ahlawat

About

Dr. Parveen Ahlawat is a distinguished radiation oncologist who has gained more than 10 years of experience in the treatment of all types of cancer. He has been working at Rajiv Gandhi Cancer Institute & Research Centre, New Delhi since 10 years.

Dr. Ahlawat holds an MBBS degree (CMC Vellore), as well as a DNB in Radiation Oncology (RGCI & RC, New Delhi), and a DM RT in Radiation Oncology (CMC Vellore). He also received training at AIIMS, New Delhi during his post-graduation studies.

Dr. Ahlawat further undertook a prestigious fellowship in oncology from the esteemed Royal Marsden Hospital, London, United Kingdom.

Dr. Ahlawat is well-known for his specialization in the treatment of head and neck cancer as well as brain tumors. He has successfully conducted several workshops to teach and train other radiation oncologists on the safe and effective delivery of radiotherapy for head and neck cancer.

Dr. Ahlawat has conducted several groundbreaking studies on head and neck cancer, which have been published in highly renowned international journals.

He is well-versed in the latest radiotherapy technology including IMRT, IGRT, SRS, SBRT, and Brachytherapy.

Furthermore, Dr. Ahlawat is incredibly passionate about his field and is actively engaged in teaching and training postgraduate radiation oncology students.

He has also delivered various talks and lectures at several international conferences.

PROFESSIONAL JOURNEY

ACHIEVEMENTS

• Training from the top medical colleges
• Undertook a prestigious fellowship in oncology from the esteemed Royal Marsden Hospital, London, United Kingdom
• Over 50 research publications pertaining to the treatment of head and neck cancers
• Has reviewed many research articles in various international journals
• Invited to teach and train other radiation oncologists about the head and neck cancer radiotherapy
• Various awards and recognition in his professional career
• Delivered various talks and lectures at several international conferences

RESEARCH AND PUBLICATIONS

• Health-related quality of life assessment for head-and-neck cancer patients during and at 3 months after radiotherapy - A prospective, analytical questionnaire-based study. National Journal of Maxillofacial Surgery. 2019.
• Prognostic factors, failure patterns and survival analysis in patients with resectable oral squamous cell carcinoma of the tongue. Radiation Oncology Journal. 2019.
• Re-irradiation with IMRT for recurrent head and neck cancer: A single-institutional report on disease control, survival, and toxicity. Reports of Practical Radiotherapy and Oncology.
• Use of definitive locoregional radiotherapy for consolidation in de-novo metastatic head and neck cancer responding to systemic therapy. Indian Journal of Cancer. 2021.
• Depth of invasion as a predictor of survival in stage III squamous cell carcinoma ofthe oral tongue. The Laryngoscope. 2021
• Tumour volumes: Predictors of early treatment response in locally advanced head and neck cancers treated with definitive chemoradiation. Reports of Practical Radiotherapy and Oncology.
• Utilization and incorporation of tumor volume data in staging and prognostication of head and neck squamous cell carcinoma treated with definitive radiotherapy: A systematic review. Asian Journal of Oncology. 2015.
• Failure patterns of head and neck squamous cell carcinoma treated with radical radiotherapy by intensity modulated radiotherapy technique using focal volume and dosimetric method. Head Neck. 2019.
• Comparison between chemotherapy (weekly cisplatin) enhanced radiotherapy and biotherapy (cetuximab) enhanced radiotherapy in locally advanced head and neck cancer – first retrospective study in Asian population. Asia-Pacific Journal Of Clinical Oncology. 2016.
• Sinonasal teratocarcinosarcoma treated with surgery followed by volumetric modulated radiotherapy: a case report with review of literature. Radiation Oncology Journal. 2018.
• Randomized controlled study comparing simultaneous modulated accelerated radiotherapy versus simultaneous integrated boost intensity modulated radiotherapy in the treatment of locally advanced head and neck cancer. Journal of the Egyptian National Cancer Institute. 2018.
• Dosimetric impact of set up errors in head and neck cancer patients treated by Image guided radiotherapy. Journal of medical physics. 2016.
• Weekly versus three-weekly cisplatin based concurrent chemoradiotherapy as definitive treatment in head and neck cancer- where do we stand? Gulf Journal of Oncology. 2016.
• Dosimetric Comparison between Intensity Modulated Radiotherapy and 3 Dimensional Conformal Radiotherapy in the Treatment of Rectal Cancer. Asian Pacific Journal of Cancer Prevention. 2016.
• Improving the accuracy of target volume delineation by combined use of CT, MRI and PET in head and neck carcinomas. Journal of Cancer Research and Therapeutics. 2015.
• Radiation-induced dental caries, prevention and treatment - A systematic review. National Journal Of Maxillofacial Surgery. 2015.
• Retrospective analysis of treatment outcomes following reirradiation in locoregionally recurrent head and neck cancer patients: A single institutional study. Asian Pacific Journal of Clinical Oncology. 2015.
• Dental Pulp Status of Posterior Teeth in Patients with Oral and Oropharyngeal Cancer Treated with Concurrent Chemoradiotherapy. Journal of Endodontics. 2015.
• Dental pulp status of posterior teeth in patients with Oral and Oropharyngeal cancer treated with radiotherapy – 1 year follow up. Journal of Endodontics. 2018.
• Cardiac dose reduction with Deep-Inspiratory Breath Hold technique of radiotherapy for left sided breast cancer. Journal of Medical Physics. 2017.
• Case report “Role of 68Ga-Prostate-Specific Membrane Antigen PET/CT in Disease Assessment in Glioblastoma Within 48 Hours of Surgery.” Clinical Nuclear Medicine. 2020.
• Prospective study of neoadjuvant chemoradiotherapy using intensity-modulated radiotherapy and 5 fluorouracil for locally advanced rectal cancer - toxicities and response assessment. Cancer Management and Research. 2018.
• Rising incidence of rectalcarcinoma in the young - Is it a concern? An Indian perspective. Cancer Prevention & Current Research. 2017.
• Male Breast Cancer: An 8-years’ experience in a single tertiary oncology centre in India. International Journal of Medical Pediatrics and Oncology. 2016.
• Rare presentation of Adenoid cystic carcinoma presenting as retro-orbital mass: a case report. Ophthalmol Case Rep. 2018.
• Long-term outcomes and toxicity with re-irradiation for recurrent/second primary head and neck cancer. Journal of Carcinogenesis. 2016.
• IMRT in carcinoma cervix – maximizing the gain and nipping the side effects – RGCI experience. Journal of Carcinogenesis. 2016.
• Simultaneous Integrated Boost to treat locally advanced squamous cell carcinoma of head and neck – A strike off between acute toxicities and early response? What do we choose? Journal of Carcinogenesis. 2016.
• Tumour Volume – Strong predictors of early treatment response in locally advanced head and neck cancers treated with definitive chemo radiation. Journal of Carcinogenesis. 2016.
• The impact of tumour regression in locally advanced carcinoma cervix during external beam radiotherapy and the need for adaptive planning. Journal of Carcinogenesis. 2016.
• Image guided interstitial brachytherapy for locally advanced disease after external beam radiotherapy in a case of carcinoma cervix – our institutional experience. Journal of Carcinogenesis. 2016.
• Comparison of the outcomes between locally advanced cervical adenocarcinoma and squamous cell carcinoma patients treated with definitive chemoradiation. Journal of Carcinogenesis. 2016.
• Correlation of MRI derived parameters and SUV uptake obtained from FDG- PET-CT with human papillomavirus status in oropharyngeal squamous cell carcinomas. Annals of Oncology. 2019.
• Incorporation of tumour volume data in predicting early outcome in locally advanced head and neck cancer treated with definitive chemoradiation. AROI 2015.
• SMART boost technique to treat locally advanced squamous cell carcinoma of head and neck how smart is it? A feasibility study. AROI 2015.
• Does local control have an impact on outcome in patients treated with re-irradiation in head and neck cancer? An institutional experience. AROICON 2012.
• Case report of vaginal melanoma. Journal of Carcinogenesis. 2016.
• Survival outcomes comparison between simultaneous integrated boost IMRT and sequential IMRT in head and neck cancers. Abstract ESTRO Spain 2021.
• Inter-Correlations Between Various High-Risk Pathological Factors in Resected Buccal Mucosal Squamous Cell Carcinoma. Abstract ASTRO Chicago 2021.
• Tumour volume as prognostic factor for recurrent head and neck cancers treated with re-irradiation. Abstract ESTRO Spain 2021.
• Would full-dose radiotherapy benefit patients with synchronous oligometastatic head and neck squamous cell carcinoma? Abstract ASTRO Chicago 2021
• Comparison between two-dose levels versus three-dose levels IMRT in head and neck cancers. Abstract ESTRO Spain 2021.
• Impact of anterior commissure involvement in early glottic cancer treated with radical IMRT. Abstract ESTRO Spain 2021
• Dosimetric impact of tumour regression in carcinoma cervix treated with radical IMRT. Abstract ESTRO Spain 2021
• Impact of human papilloma virus on treatment outcomes in oropharyngeal cancer in India. Abstract ESTRO Spain 2021
• Pre-treatment hemoglobin as a surrogate marker for survival in head and neck squamous cell carcinoma. Abstract ESTRO Spain 2021
• Simultaneous integrated boost IMRT versus sequential IMRT in head and neck cancers. Abstract ESTRO Spain 2021.
• Comparison of therapy outcomes between 2-dimensional radiotherapy and IMRT for early glottic cancer. Abstract ESTRO Spain 2021.
• Wide histological spectrum of sinonasal malignancies and survival outcomes – an institutional review. Abstract ESTRO Spain 2021.
• Use of definitive locoregional radiotherapy for consolidation in de-novo metastatic head and neck cancer responding to systemic therapy. Abstract ESTRO Spain 2021.